top of page
LATEST PROJECTS
“True liberty, by protecting the exertions of talents and industry, and securing to them their justly acquired fruits, tends more powerfully than any other cause to augment the mass of national wealth.”
— Alexander Hamilton, Defense of the Funding System
LETTER
QALY Ban
Though the U.S. health system remains one of the most free-enterprise health systems in the world, elements of government-run health systems have entered our system. Budget- focused government bureaucrats in socialized health systems use cruel tools such as QALYs to rationalize denying needed medical treatment to those patients in the most need.
COMMENT LETTER
Initiatives to Ensure the Robustness and Reliability of Patent Rights
There are dangers in breathing unproven antitrust theory into patent policy. Neo- Brandeisian antitrust proponents have serious difficulty coming to grips with the fact that patent exclusivity is the lifeblood of invention; the essence of robust, reliable patent rights; the key to commercialization of patented inventions; and the foundation of dynamic competition.
COALITION LETTER
Support WOTUS Rule CRA
Our coalition commends H.J.Res. 27 for prioritizing the restoration of the pre-2015 interpretation of the Clean Water Act. Under the Biden WOTUS rule like its Obama predecessor, more than 60 percent of the nation’s streams and millions of acres of wetlands could be swept into federal jurisdiction supposedly as “navigable waters.”
COALITION LETTER
Support the Braun/Barr CRA Resolution on ESG
A pernicious practice known as Environmental, Social, and Governance (ESG) investing has emerged over the past several decades. Rather than prioritize the financial well-being and stability of retirees, ESG seeks to advance ideological goals related to environmental policy and other divisive subjects.
COMMENT LETTER
Regarding Joint USPTO–FDA Collaboration Initiatives
The consequences of the Patent and Trademark Office’s (PTO) and the Food and Drug Administration’s (FDA) getting it wrong here will profoundly jeopardize the health and lives of millions of suffering patients in the United States and around the world.
COALITION LETTER
Interagency Patent Coordination
The Interagency Patent Coordination and Improvement Act, would unduly expand PTO’s and FDA’s missions; undermine technological neutrality, a core quality of the U.S. patent system; risk disclosing confidential and proprietary information; and hamper U.S. innovation.
AMICUS BRIEF
Samsung Electronics v. Netlist
Samsung petitioned IPR proceedings at the request of Google, a time-barred real party in interest that failed multiple tries to invalidate the challenged claim. PTAB granted IPR, ignoring the Federal Circuit's In re Vivint and its own precedential General Plastic test.
AMICUS BRIEF
OpenSky, Intel, & PQA v. VLSI at PTAB
It should be a “red flag” suggestive of abuse when a petitioner would not otherwise have Article III standing in court; when a petitioner seeks to undue an existing district court judgment, where the patent has already survived examination in court; when the apparent motive of the PTAB challenge is to impose cost and burden for litigation leverage.
COALITION LETTER
Opposition to S. 2992
Sen. Amy Klobuchar’s antitrust bill, the American Innovation and Choice Online Act, gives the Biden administration vast new regulatory authority over American businesses, fails to address conservative censorship concerns and would make inflation worse for American families.
STATEMENT
Senate PDUFA Should Drop Dangerous Drug Importation
Drug importation is inherently high-risk. No HHS secretary, Republican or Democratic, from 1987 until 2020 dared to deem importation as safe for patients or significantly cost-saving for U.S. consumers. Nothing’s changed. Drug importation risks harm from adulterated or counterfeit pharmaceuticals.
AMICUS BRIEF
Palo Alto Networks v. Centripetal Networks
CPR strongly supports Centripetal Networks’s request for rehearing and POP review of the decision instituting IPR. Centripetal won in Article III court. Palo Alto is gaming the system to get leverage in separate litigation involving different patents.
COALITION LETTER
80 Conservatives Oppose 95% Rx Tax
In a time of inflation levels not seen in decades, the last thing Americans need is a 95% tax that would nearly double the price of the prescription medicines they need to live healthy and fulfilling lives. A price control to avoid the tax isn’t a better option.
COALITION LETTER
ATR-Led Oppo to TRIPS Waiver on American Innovation
Waiving TRIPS would allow foreign countries to immediately seize patents and clinical data of American businesses in order to attempt to produce COVID-19 vaccines. This would give foreign countries access to sensitive, valuable proprietary information belonging to American businesses.
LETTER
CPR Support for S. 3772 to Stop Chinese Courts
The Defending American Courts Act ensures that intellectual property owners have access to U.S. courts and can exercise their American IP rights. S. 3772 would constrain the use of a disturbing, growing practice of certain foreign courts, particularly in China.
LETTER
Budget Reconciliation & Inflation
H.R. 5376 will worsen the hidden "tax" of inflation, already reaching the highest level in 30 years. Inflationary pressures will stem from the climate provisions, adverse effects on our mature domestic energy industry, government price controls that will stifle U.S. innovation and competitiveness, and massive new government spending.
LETTER
The Restoring America's Leadership in Innovation Act
H.R. 5874, the Restoring America’s Leadership in Innovation Act, would strengthen private property rights in one’s inventions and discoveries. The bill would go a long way toward reversing the antipatent onslaught of recent years. RALIA would counter the sustained assault by courts, Congress, the Administrative State, and patent-infringer interests.
STATEMENT
Support for RSC's Countering Communist China Act
The Republican Study Committee has crafted effective legislation in the Countering Communist China Act. Its comprehensive approach reflects the fact that America’s industrial competitiveness is at stake when adversaries can freely break the rules, conduct espionage and plunder American private property — especially patents and other IP.
CPAC panel on patent property rights with, L-R, CPR Executive Director Jim Edwards, CPR member-Tea Party Patriots' Jenny Beth Martin and USPTO Director Andrei Iancu.
Statements of Principles
bottom of page